Skip to main content

Advertisement

SpringerLink
Log in

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects

  • Letter
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yamagishi S, Imaizumi T (2005) Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy. Curr Pharm Des 11:2279–2299

    Article  PubMed  CAS  Google Scholar 

  2. Park L, Raman KG, Lee KJ et al (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat Med 4:1025–1031

    Article  PubMed  CAS  Google Scholar 

  3. Enomoto M, Adachi H, Yamagishi S et al (2006) Positive association of serum levels of advanced glycation end products with thrombogenic markers in humans. Metabolism 55:912–917

    Article  PubMed  CAS  Google Scholar 

  4. Nakamura K, Yamagishi S, Adachi H et al (2007) Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med 3:185–189

    Google Scholar 

  5. Humpert PM, Djuric Z, Kopf S et al (2007) Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes. Cardiovascular Diabetology 6:9

    Article  PubMed  Google Scholar 

  6. Steiner M, Reinhardt KM, Krammer B et al (1994) Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemost 72:979–984

    PubMed  CAS  Google Scholar 

  7. Nakamura K, Yamagishi S, Nakamura Y et al (2005) Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc Res 70:137–141

    Article  PubMed  CAS  Google Scholar 

  8. Pachydaki SI, Tari SR, Lee SE et al (2006) Upregulation of RAGE and its ligands in proliferative retinal disease. Exp Eye Res 82:807–815

    Article  PubMed  CAS  Google Scholar 

  9. Miura J, Yamamoto Y, Osawa M et al (2007) Endogenous secretory receptor for advanced glycation endproducts levels are correlated with serum pentosidine and CML in patients with type 1 diabetes. Arterioscler Thromb Vasc Biol 27:253–254

    Article  PubMed  Google Scholar 

  10. Koyama H, Shoji T, Yokoyama H et al (2005) Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 25:2587–2593

    Article  PubMed  CAS  Google Scholar 

  11. Kass DA, Shapiro EP, Kawaguchi M et al (2001) Improved arterial compliance by a novel advanced glycation endproduct crosslink breaker. Circulation 104:1464–1470

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nakamura Clinic, Kita-Kyushu, Japan

    K. Nakamura

  2. Department of Medicine, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011, Japan

    K. Nakamura, S.I. Yamagishi, T. Matsui, H. Adachi & T. Imaizumi

  3. Department of Pathophysiological Science, Hokuriku University, Kanazawa, Japan

    M. Takeuchi

Authors
  1. K. Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S.I. Yamagishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Matsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Adachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Imaizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S.I. Yamagishi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nakamura, K., Yamagishi, S., Matsui, T. et al. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects. Clin. Exper.Med. 7, 188–190 (2007). https://doi.org/10.1007/s10238-007-0146-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-007-0146-7

Keywords

Search

Navigation